These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 7957388)

  • 1. Carnitine esters in metabolic disease.
    Böhles H; Evangeliou A; Bervoets K; Eckert I; Sewell A
    Eur J Pediatr; 1994; 153(7 Suppl 1):S57-61. PubMed ID: 7957388
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of metabolic mimicry.
    Karnovsky ML
    N Engl J Med; 1979 Dec; 301(26):1442-3. PubMed ID: 514325
    [No Abstract]   [Full Text] [Related]  

  • 3. [Carnitine--an essential substance. Action and role].
    Martina B
    Schweiz Rundsch Med Prax; 1992 Aug; 81(33):949-50. PubMed ID: 1529183
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of gene defects in branched-chain amino acid metabolism by tandem mass spectrometry of carnitine esters produced by cultured fibroblasts.
    Roe CR; Roe DS
    Methods Enzymol; 2000; 324():424-31. PubMed ID: 10989450
    [No Abstract]   [Full Text] [Related]  

  • 5. Surprising causes of C5-carnitine false positive results in newborn screening.
    Boemer F; Schoos R; de Halleux V; Kalenga M; Debray FG
    Mol Genet Metab; 2014 Jan; 111(1):52-4. PubMed ID: 24291264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prolonged moderate-intensity exercise without and with L-carnitine supplementation in patients with MCAD deficiency.
    Huidekoper HH; Schneider J; Westphal T; Vaz FM; Duran M; Wijburg FA
    J Inherit Metab Dis; 2006 Oct; 29(5):631-6. PubMed ID: 16972171
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Carnitine deficiency in inborn errors of metabolism].
    Sela BA; Lerman-Sagie T; Berkovitz M
    Harefuah; 1997 Nov; 133(10):419-23, 504. PubMed ID: 9418309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A case of glutaric acidemia type I: effect of riboflavin and carnitine.
    Lipkin PH; Roe CR; Goodman SI; Batshaw ML
    J Pediatr; 1988 Jan; 112(1):62-5. PubMed ID: 3335963
    [No Abstract]   [Full Text] [Related]  

  • 9. Carnitine disorders.
    Stanley CA
    Adv Pediatr; 1995; 42():209-42. PubMed ID: 8540429
    [No Abstract]   [Full Text] [Related]  

  • 10. Carnitine therapy and metabolism in the disorders of propionyl-CoA metabolism studied using 1H-NMR spectroscopy.
    Davies SE; Iles RA; Stacey TE; de Sousa C; Chalmers RA
    Clin Chim Acta; 1991 Dec; 204(1-3):263-77. PubMed ID: 1819469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of carnitine administration on glycine metabolism in patients with isovaleric acidemia: significance of acetylcarnitine determination to estimate the proper carnitine dose.
    Itoh T; Ito T; Ohba S; Sugiyama N; Mizuguchi K; Yamaguchi S; Kidouchi K
    Tohoku J Exp Med; 1996 Jun; 179(2):101-9. PubMed ID: 8875766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teaching NeuroImages: Glutaric aciduria type 1 (glutaryl-CoA dehydrogenase deficiency).
    Singh P; Goraya JS; Ahluwalia A; Saggar K
    Neurology; 2011 Jul; 77(1):e6. PubMed ID: 21727264
    [No Abstract]   [Full Text] [Related]  

  • 13. Neonatal onset of hyperornithinemia-hyperammonemia-homocitrullinuria syndrome with favorable outcome.
    Zammarchi E; Ciani F; Pasquini E; Buonocore G; Shih VE; Donati MA
    J Pediatr; 1997 Sep; 131(3):440-3. PubMed ID: 9329423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carnitine deficiency in lysinuric protein intolerance: lysine-sparing effect of carnitine.
    Takada G; Goto A; Komatsu K; Goto R
    Tohoku J Exp Med; 1987 Dec; 153(4):331-4. PubMed ID: 3126568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enzymatic evaluation of glutaric acidemia type 1 by an in vitro probe assay of acylcarnitine profiling using fibroblasts and electrospray ionization/tandem mass spectrometry (MS/MS).
    Mushimoto Y; Hasegawa Y; Kobayashi H; Li H; Purevsuren J; Nakamura I; Taketani T; Fukuda S; Yamaguchi S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Sep; 877(25):2648-51. PubMed ID: 19467937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Inborn metabolic errors due to disorders in the urea synthesis cycle].
    Kardosová A; Hruskovic I; Strnová J
    Cesk Pediatr; 1986 Jan; 41(1):31-3. PubMed ID: 3948272
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnosis of urea cycle disorders.
    Bachmann C
    Enzyme; 1987; 38(1-4):233-41. PubMed ID: 3440447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transport and functions of carnitine in muscles.
    Siliprandi N; Di Lisa F; Menabó R; Ciman M; Sartorelli L
    J Clin Chem Clin Biochem; 1990 May; 28(5):303-6. PubMed ID: 2199594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human plasmalemmal carnitine transporter defect is expressed in cultured lymphoblasts: a new non-invasive method for diagnosis.
    Tein I; Xie ZW
    Clin Chim Acta; 1996 Aug; 252(2):201-4. PubMed ID: 8853567
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of L-carnitine on cerebral and hepatic energy metabolites in congenitally hyperammonemic sparse-fur mice and its role during benzoate therapy.
    Ratnakumari L; Qureshi IA; Butterworth RF
    Metabolism; 1993 Aug; 42(8):1039-46. PubMed ID: 8102193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.